These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 20030799)
1. In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA. Guardabassi L; Ghibaudo G; Damborg P Vet Dermatol; 2010 Jun; 21(3):282-6. PubMed ID: 20030799 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of propolis extract against Staphylococcus coagulase positive and Malassezia pachydermatis of canine otitis. Cardoso RL; Maboni F; Machado G; Alves SH; de Vargas AC Vet Microbiol; 2010 May; 142(3-4):432-4. PubMed ID: 19913365 [TBL] [Abstract][Full Text] [Related]
3. Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions. Clark SM; Loeffler A; Schmidt VM; Chang YM; Wilson A; Timofte D; Bond R Vet Dermatol; 2016 Oct; 27(5):340-e84. PubMed ID: 27406860 [TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates. Boyen F; Verstappen KM; De Bock M; Duim B; Weese JS; Schwarz S; Haesebrouck F; Wagenaar JA Vet Dermatol; 2012 Aug; 23(4):381-5, e70. PubMed ID: 22409321 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. Clark SM; Loeffler A; Bond R J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility. Sheng WH; Wang JT; Lauderdale TL; Weng CM; Chen D; Chang SC Diagn Microbiol Infect Dis; 2009 Mar; 63(3):309-13. PubMed ID: 19216941 [TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. Ganière JP; Médaille C; Etoré F Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955 [TBL] [Abstract][Full Text] [Related]
8. [In-vivo efficacy of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA. A randomised, placebo-controlled, double-blinded comparative trial]. Bouassiba C; Osthold W; Mueller RS Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):161-70. PubMed ID: 22688793 [TBL] [Abstract][Full Text] [Related]
9. Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis. Farca AM; Piromalli G; Maffei F; Re G J Small Anim Pract; 1997 Jun; 38(6):243-5. PubMed ID: 9200113 [TBL] [Abstract][Full Text] [Related]
10. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa. Penna B; Varges R; Medeiros L; Martins GM; Martins RR; Lilenbaum W Vet Dermatol; 2010 Jun; 21(3):292-6. PubMed ID: 20042036 [TBL] [Abstract][Full Text] [Related]
11. [Bactericidal activity determination of Biseptine, combination of chlorhexidine, benzalkonium chloride and benzylic alcohol, on 124 hospital bacterial strains]. Reverdy ME; Martra A; Fleurette J Pathol Biol (Paris); 1997 Apr; 45(4):331-5. PubMed ID: 9296082 [TBL] [Abstract][Full Text] [Related]
12. Effect of chlorhexidine/EDTA/Tris against bacterial isolates from clinical specimens. Harper WE; Epis JA Microbios; 1987; 51(207):107-12. PubMed ID: 3116368 [TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of a honey-based gel against canine clinical isolates of Staphylococcus pseudintermedius and Malassezia pachydermatis. Oliveira AMP; Devesa JSP; Hill PB Vet Dermatol; 2018 Jun; 29(3):180-e65. PubMed ID: 29569291 [TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial activity of a gel containing antimicrobial peptide AMP2041, chlorhexidine digluconate and Tris-EDTA on clinical isolates of Pseudomonas aeruginosa from canine otitis. Ghibaudo G; Santospirito D; Sala A; Flisi S; Taddei S; Cavirani S; Cabassi CS Vet Dermatol; 2016 Oct; 27(5):391-e98. PubMed ID: 27545352 [TBL] [Abstract][Full Text] [Related]
15. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs. Zamankhan Malayeri H; Jamshidi S; Zahraei Salehi T Vet Res Commun; 2010 Jun; 34(5):435-44. PubMed ID: 20526674 [TBL] [Abstract][Full Text] [Related]
16. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa. Lyskova P; Vydrzalova M; Mazurova J J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):559-63. PubMed ID: 18045339 [TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs. Valentine BK; Dew W; Yu A; Weese JS Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369 [TBL] [Abstract][Full Text] [Related]
19. [A bacteriological study of otitis in dogs (author's transl)]. Moreno G; Figueiredo C; Lopes CA Arq Inst Biol (Sao Paulo); 1975; 42():297-300. PubMed ID: 1236059 [TBL] [Abstract][Full Text] [Related]
20. A pilot study comparing in vitro efficacy of topical preparations against veterinary pathogens. Uri M; Buckley LM; Marriage L; McEwan N; Schmidt VM Vet Dermatol; 2016 Jun; 27(3):152-e39. PubMed ID: 27109449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]